PROYECTOS EUROPEOS
Project DIRNANO DIRNANO
Directing the immune response through designed nanomaterials
date_range
Duration: from 01 October 2020 to 30 September 2024
(48 months)
euro
259,904.00 EUR
Of European scope.
Researchers
Publications related to the project
Show by yearConference Poster
-
Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate
2023
VI RSEQ Chemical Biology Group Meeting - ChemBio VI
-
Structure-guided design of unnatural Mucin-1 biomimetics for the development of cancer therapeutic nano-vaccines and diagnostic assays
2023
4th Regular Meeting of the DIRNANO consortium
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models
2023
3rd Regular Meeting of the DIRNANO consortium
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models & biosensor development
2023
5th Regular Meeting of the DIRNANO consortium
Conference paper
-
Directing the immune response through designed nanomaterial. Winter School Presentation
2022
Winter School of the DIRNANO consortium
-
Directing the immune response through designed nanomaterials. Progress Report
2022
1st Regular Meeting of the DIRNANO consortium
Related research data
- PRESENTATION 2nd Regular Meeting of the DIRNANO consortium; ESR14